The use of Lyrica (pregabalin) in combination with opioids can lead to an increased risk of adverse effects. [1] Lyrica is a medication primarily used to treat fibromyalgia, nerve pain, and epilepsy. However, it has been observed that co-administration of Lyrica with opioids can result in enhanced sedative effects, respiratory depression, and increased risk of falls. [2]

According to the prescribing information for Lyrica, the manufacturer, Pfizer, recommends that patients receiving opioids should start with a low dose of Lyrica and gradually increase it to minimize the risk of adverse effects. [3] Additionally, patients should be closely monitored for signs of excessive sedation, respiratory depression, or other adverse effects.

It is essential to note that the risk of adverse effects with Lyrica and opioids may be mitigated by closely monitoring patients and adjusting their dosage accordingly. Patients should be informed about the potential risks and benefits of co-administering these medications.

References:
[1] DrugPatentWatch.com - Pregabalin (LYRICA) | FDA Labeling & Side Effects.
[2] Pregabalin Monograph for Professionals | Drugs.com.
[3] LYRICA (pregabalin) capsules, tablets, and oral solution | Pfizer Labeling.

Please consult the linked sources for more information:
1. https://www.drugpatentwatch.com/labeling/lyrica
2. https://www.drugs.com/monograph(pregabalin-oral.html)
3. https://www.pfizermedicalinformation.com/en-us/lyrica